Diabetes

Gemigliptin, metformin combo beats monotherapy in T2DM

(HealthDay)—Gemigliptin combined with metformin is superior to monotherapy with either drug for patients with type 2 diabetes mellitus (T2DM), according to a study published online Sept. 13 in Diabetes, Obesity and Metabolism.

Diabetes

Metformin influences nitrogen and urea metabolism

The most frequently prescribed oral antidiabetic drug metformin significantly affects metabolic pathways. This was reported by scientists from the Helmholtz Zentrum München together with colleagues from the German Diabetes ...

Diabetes

Older drug may help type 1 diabetics' heart health

(HealthDay)—An inexpensive medication normally given to people with type 2 diabetes may help preserve heart health in people with the less common form of diabetes—type 1, a small new study finds.

Diabetes

Metformin, sitagliptin prolong normoglycemia remission in DKA

(HealthDay)—For patients with new-onset diabetic ketoacidosis (DKA) and severe hyperglycemia, metformin and sitagliptin treatment after normoglycemia remission correlate with increased relapse-free survival and prolonged ...

Diabetes

Metformin linked to increased risk of acute dialysis in T2DM

(HealthDay)—For patients with type 2 diabetes, metformin is associated with about a 50 percent increase in the risk of acute dialysis compared to sulfonylureas, according to a study published online Aug. 18 in Diabetes, ...

page 17 from 32